Aevice Health Secures $7 Million to Advance Global Respiratory Care

Aevice Health, a Singapore-based digital health pioneer, has raised US$7 million in a seed plus funding round. The new capital will accelerate its growth in the US, Japan, and Singapore.

• Innovative Wearables: Aevice Health has developed remote patient monitors specifically for chronic respiratory conditions. Their flagship product, AeviceMD, is the world’s smallest smart wearable stethoscope, monitoring respiratory rate, heart rate, and wheezing.

• Investors Involved: The funding round was led by Coronet Ventures, the Singapore-based venture unit of Cedars-Sinai Intellectual Property. East Ventures and Seeds Capital, the corporate investment arm of Enterprise Singapore, also participated in this round.

• Product Development Boost: The funds will enhance Aevice Health’s product offerings, aiming to make their solutions as common in homes as thermometers for managing chronic respiratory diseases.

• Strategic Moves: The startup has received approvals for AeviceMD in the US and Singapore and partnered with Japanese medical equipment manufacturer A&D.

With these developments, Aevice Health is poised to make significant strides in global respiratory care.